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University Hospital, Karachi. ) 
S. M. Rab ( Departments of Medicine, The Aga Khan University Hospital, Karachi. ) 
Myelofibrosis w’ith myeloid metaplasia (MMM) is usually considered primary agnogenic, however, it
may be secondary to various diseases, The association of tuberculosis with MMM is exceedingly rare,
however, the pathogenetic relationship between the two is difficult to define. We present a case report
showing simultaneous presentation of localized active tuberculosis and MMM The literature on the
subject is also reviewed w’ith special emphasis on pathogenic relationship between the two.
Case Report 
A 28 year old thin build man presented with generalized Weakness, weight loss and progressively
increasing pallor since one and a half years. Two weeks before attending the medicine clinic, he
developed low grade fever and also noticed a nodular swelling on left side of the neck, On
exatnination, lie was found to have severe anaemia, hepatosplenomegaly and enlarged scalene lymph
node on left side of the neck. Laboratoiy work up revealed Hb 3.0 gm/dl, a leukoeiythroblastic picture
with many teal’ drop shaped red cells. The bone marrow aspiration was difficult and yielded a dry lap.
Subsequent bone trephine biopsy revealed a cellular marrow with large number of mature and
immature megakaryocytes and markedly increased marrow fibrosis which was confirmed by reticulin
stain (Figure 1).
Fine needle aspiration of scalene lymph node was carried out which showed few atypical cells with
hyperchromatic nuclei and epithelioid cells in a lympho cytic background. The possibility of Hodgkin’s
disease was questioned with recommendation of histological evaluation. The excisional biopsy of lymh
node revealed extrarnedullary hernatopoicsis and caseating granulomas compatible with tuberculosis
(Figure 2).
AFB stain was negative. No evidence of pulmonary or military tuberculosis was found.
The patient was started on antituberculous therapy and within days the fever subsided with marked
clinical improvement. A hcmatological assessment made after 3 months revealed haemoglobin level of
6.0 gm/dl and a weight gain of 2.2 kg. After completion of the therapy, the patient was well with a
hacmoglobin level of 10.2 gm/dl.
Discussion 
Mycloscierosis with myeloid metaplasia is grouped under the heading of myeloproliferative disorders
and is characterized by splenomegaly. presence of immature granulocytes and erythroblasts together
with distorted and tear drop shaped red cells in the peripheral blood and marrow fibrosis. It is usually
considered agnogenic and many synonyms have been applied to this disease including agnogenic
myeloid metaplasia. chronic primary inyelosclerosis, chronic fibrogenie megakarrocytic leukemia1 and
megakaiyocytic myelosis2. The neoplastic character of the disease has been established by
demonstrating the clonal replication of the erythrocytic, granulocytic and megakaiyocytic lineages. The
fibroblastic proliferation on the other hand is not clonal and is reactive rather than neoplastic3. The
enhanced collagen content of marrow is the result of release offibroblastic growth factors especially
platelet derived growth factor (PDGF), tmnsforiniiig growth facior B (TGF-B), tumour necrosis factor
alpha (TNF-alpha) and interleukin 1, released from megakaryocytes and other marrow cells. The
reactive nature of the fibroblastic proliferation is determined by isoenzyme studies or chromosomal
karyotyping4.
A number of cases of MMIM may follow secondary to vanous diseases including polycythemia vera,
essential thrombocythemia. leukaemia and metastatic carcinoma. Exposure to benzene and ionizing
radiation has also been described in genesis of MIvIM. Another less well recognized condition with
MMM is tuberculosis. The tuberculosis in these cases either presents as isolated pulmonary disease or
as localized caseous or granulomatous disease of blood forming organs including spleen, lymph nodes
and liver. In some cases, the disease presents as miliary tuberculosis5. The pathogenetic relationship
between tuberculosis and MMM is complex and difficult to define. Various explanations for the co-
existence of tuberculosis and MMM have been described. The findings may be a mere coincidence, or
the blood disorder or its treatment may lead to an increased susceptibility to tuberculosis. Few studies
favour the tuberculous infection as a cause of MMM6,7.
Tuberculosis is very common in this part of the world and localized as well as miliary tuberculosis is’
frequently seen in clinical practice. MMM is an uncommon hematological disorder and most of the
cases are either agnogenic or secondary to polycythemia vera and leukaeniia. In our case, the
remarkable hematological improvement achieved within three months of anti- tuberculous treatment
points towards the possible causative role in myelofibrosis. This case report also points to the important
fact that despite a high incidence of tuberculosis in our country the myelofibrosis in association with
tuberculosis infection has not been cited in local literature. It could be due to limited medical facilities,
improper follow-up of the patients or lack of awareness of the possibility of tuberculous infection in
cases of mvelofibrosis. Thus, it seems that the incidence of MMM may be much higher in our
population and a painstaking search should be made to find out tuberculous infection in a case of
myelofibrosis or vice versa. The importance of tuberculosis in the myeloproliferative disease cannot be
under-estimated both from the point of view of management of the patient, as well as an understanding
of the nature of blood disorder.
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